GRAPPA Treatment Recommendations: An Update From the 2020 GRAPPA Annual Meeting

As part of the supplement series GRAPPA 2020, this report was reviewed internally and approved by the Guest Editors for integrity, accuracy, and consistency with scientific and ethical standards. L.C. Coates, MB ChB, PhD, National Institute for Health Research Clinician Scientist, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK; N. Corp, PhD, D.A. van der Windt, PhD, Primary Care Centre Versus Arthritis, School of Medicine, Keele University, Staffordshire, UK; E.R. Soriano, MD, MSc, Rheumatology Unit, Internal Medicine Services, Hospital Italiano de Buenos Aires, and University Institute Hospital Italiano de Buenos Aires, Buenos Aires, Argentina; A. Kavanaugh, MD, Division of Rheumatology Allergy and Immunology, University of California, San Diego, La Jolla, California, USA. LCC has received grant/research support from AbbVie, Amgen, Celgene, Eli Lilly, Gilead, Janssen, Novartis, Pfizer, and UCB, and honoraria or consulting fees from AbbVie, Amgen, Biogen, Boehringer-Ingelheim, BMS, Celgene, Eli Lilly, Janssen, Medac, Novartis, Pfizer, and UCB. ERS has received grant/research support from AbbVie, BMS, Janssen, Novartis, Pfizer, Roche, and UCB, and honoraria or consulting fees from AbbVie, Amgen, BMS, Celgene, Eli Lilly, Janssen, Novartis, Pfizer, Roche, Sanofi, and UCB. AK has received grant/research support from AbbVie, Amgen, Eli Lilly, Gilead, Janssen, Novartis, Pfizer, and UCB, and honoraria and/or consulting fees from AbbVie, Boehringer-Ingelheim, BMS, Eli Lilly, Janssen, Medac, Novartis, Pfizer, and UCB. NC and DAvdW have no conflicts of interest. Address correspondence to Dr. A. Kavanaugh, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92037-0943, USA. Email: akavanaugh@health.ucsd.edu.

As part of the supplement series GRAPPA 2020, this report was reviewed internally and approved by the Guest Editors for integrity, accuracy, and consistency with scientific and ethical standards. L.C. Coates, MB ChB, PhD, National Institute for Health Research Clinician Scientist, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK; N. Corp, PhD, D.A. van der Windt, PhD, Primary Care Centre Versus Arthritis, School of Medicine, Keele University, Staffordshire, UK; E.R. Soriano, MD, MSc, Rheumatology Unit, Internal Medicine Services, Hospital Italiano de Buenos Aires, and University Institute Hospital Italiano de Buenos Aires, Buenos Aires, Argentina; A. Kavanaugh, MD, Division of Rheumatology Allergy and Immunology, University of California, San Diego, La Jolla, California, USA. LCC has received grant/research support from AbbVie, Amgen, Celgene, Eli Lilly, Gilead, Janssen, Novartis, Pfizer, and UCB, and honoraria or consulting fees from AbbVie, Amgen, Biogen, Boehringer-Ingelheim, BMS, Celgene, Eli Lilly, Janssen, Medac, Novartis, Pfizer, and UCB. ERS has received grant/research support from AbbVie, BMS, Janssen, Novartis, Pfizer, Roche, and UCB, and honoraria or consulting fees from AbbVie, Amgen, BMS, Celgene, Eli Lilly, Janssen, Novartis, Pfizer, Roche, Sanofi, and UCB. AK has received grant/research support from AbbVie, Amgen, Eli Lilly, Gilead, Janssen, Novartis, Pfizer, and UCB, and honoraria and/or consulting fees from AbbVie, Boehringer-Ingelheim, BMS, Eli Lilly, Janssen, Medac, Novartis, Pfizer, and UCB. NC and DAvdW have no conflicts of interest. Address correspondence to Dr. A. Kavanaugh, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92037-0943, USA. Email: akavanaugh@health.ucsd.edu.

As part of the supplement series GRAPPA 2020, this report was reviewed internally and approved by the Guest Editors for integrity, accuracy, and consistency with scientific and ethical standards. L.C. Coates, MB ChB, PhD, National Institute for Health Research Clinician Scientist, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK; N. Corp, PhD, D.A. van der Windt, PhD, Primary Care Centre Versus Arthritis, School of Medicine, Keele University, Staffordshire, UK; E.R. Soriano, MD, MSc, Rheumatology Unit, Internal Medicine Services, Hospital Italiano de Buenos Aires, and University Institute Hospital Italiano de Buenos Aires, Buenos Aires, Argentina; A. Kavanaugh, MD, Division of Rheumatology Allergy and Immunology, University of California, San Diego, La Jolla, California, USA. LCC has received grant/research support from AbbVie, Amgen, Celgene, Eli Lilly, Gilead, Janssen, Novartis, Pfizer, and UCB, and honoraria or consulting fees from AbbVie, Amgen, Biogen, Boehringer-Ingelheim, BMS, Celgene, Eli Lilly, Janssen, Medac, Novartis, Pfizer, and UCB. ERS has received grant/research support from AbbVie, BMS, Janssen, Novartis, Pfizer, Roche, and UCB, and honoraria or consulting fees from AbbVie, Amgen, BMS, Celgene, Eli Lilly, Janssen, Novartis, Pfizer, Roche, Sanofi, and UCB. AK has received grant/research support from AbbVie, Amgen, Eli Lilly, Gilead, Janssen, Novartis, Pfizer, and UCB, and honoraria and/or consulting fees from AbbVie, Boehringer-Ingelheim, BMS, Eli Lilly, Janssen, Medac, Novartis, Pfizer, and UCB. NC and DAvdW have no conflicts of interest. Address correspondence to Dr. A. Kavanaugh, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92037-0943, USA. Email: akavanaugh@health.ucsd.edu.

As part of the supplement series GRAPPA 2020, this report was reviewed internally and approved by the Guest Editors for integrity, accuracy, and consistency with scientific and ethical standards. L.C. Coates, MB ChB, PhD, National Institute for Health Research Clinician Scientist, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK; N. Corp, PhD, D.A. van der Windt, PhD, Primary Care Centre Versus Arthritis, School of Medicine, Keele University, Staffordshire, UK; E.R. Soriano, MD, MSc, Rheumatology Unit, Internal Medicine Services, Hospital Italiano de Buenos Aires, and University Institute Hospital Italiano de Buenos Aires, Buenos Aires, Argentina; A. Kavanaugh, MD, Division of Rheumatology Allergy and Immunology, University of California, San Diego, La Jolla, California, USA. LCC has received grant/research support from AbbVie, Amgen, Celgene, Eli Lilly, Gilead, Janssen, Novartis, Pfizer, and UCB, and honoraria or consulting fees from AbbVie, Amgen, Biogen, Boehringer-Ingelheim, BMS, Celgene, Eli Lilly, Janssen, Medac, Novartis, Pfizer, and UCB. ERS has received grant/research support from AbbVie, BMS, Janssen, Novartis, Pfizer, Roche, and UCB, and honoraria or consulting fees from AbbVie, Amgen, BMS, Celgene, Eli Lilly, Janssen, Novartis, Pfizer, Roche, Sanofi, and UCB. AK has received grant/research support from AbbVie, Amgen, Eli Lilly, Gilead, Janssen, Novartis, Pfizer, and UCB, and honoraria and/or consulting fees from AbbVie, Boehringer-Ingelheim, BMS, Eli Lilly, Janssen, Medac, Novartis, Pfizer, and UCB. NC and DAvdW have no conflicts of interest. Address correspondence to Dr. A. Kavanaugh, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92037-0943, USA. Email: akavanaugh@health.ucsd.edu.

As part of the supplement series GRAPPA 2020, this report was reviewed internally and approved by the Guest Editors for integrity, accuracy, and consistency with scientific and ethical standards. L.C. Coates, MB ChB, PhD, National Institute for Health Research Clinician Scientist, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK; N. Corp, PhD, D.A. van der Windt, PhD, Primary Care Centre Versus Arthritis, School of Medicine, Keele University, Staffordshire, UK; E.R. Soriano, MD, MSc, Rheumatology Unit, Internal Medicine Services, Hospital Italiano de Buenos Aires, and University Institute Hospital Italiano de Buenos Aires, Buenos Aires, Argentina; A. Kavanaugh, MD, Division of Rheumatology Allergy and Immunology, University of California, San Diego, La Jolla, California, USA. LCC has received grant/research support from AbbVie, Amgen, Celgene, Eli Lilly, Gilead, Janssen, Novartis, Pfizer, and UCB, and honoraria or consulting fees from AbbVie, Amgen, Biogen, Boehringer-Ingelheim, BMS, Celgene, Eli Lilly, Janssen, Medac, Novartis, Pfizer, and UCB. ERS has received grant/research support from AbbVie, BMS, Janssen, Novartis, Pfizer, Roche, and UCB, and honoraria or consulting fees from AbbVie, Amgen, BMS, Celgene, Eli Lilly, Janssen, Novartis, Pfizer, Roche, Sanofi, and UCB. AK has received grant/research support from AbbVie, Amgen, Eli Lilly, Gilead, Janssen, Novartis, Pfizer, and UCB, and honoraria and/or consulting fees from AbbVie, Boehringer-Ingelheim, BMS, Eli Lilly, Janssen, Medac, Novartis, Pfizer, and UCB. NC and DAvdW have no conflicts of interest. Address correspondence to Dr. A. Kavanaugh, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92037-0943, USA. Email: akavanaugh@health.ucsd.edu.